SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-13
DOI
10.3389/fmicb.2022.856757
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China
- (2022) Min Kang et al. ANNALS OF INTERNAL MEDICINE
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
- (2021) Shixiong Hu et al. Nature Communications
- Coronavirus variants are spreading in India — what scientists know so far
- (2021) Gayathri Vaidyanathan NATURE
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Erik Volz et al. NATURE
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color
- (2021) Carla Cerami et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility — Oklahoma, April–May 2021
- (2021) Kendra Dougherty et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
- (2021) Mahesh S. Dhar et al. SCIENCE
- Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
- (2021) Mark J. Siedner et al. JCI Insight
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Household Transmission of SARS-CoV-2, Zhuhai, China, 2020
- (2020) Jian Wu et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV-2 (COVID-19): What do we know about children? A systematic review
- (2020) Nisha S Mehta et al. CLINICAL INFECTIOUS DISEASES
- The characteristics of household transmission of COVID-19
- (2020) Wei Li et al. CLINICAL INFECTIOUS DISEASES
- Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study
- (2020) Qin-Long Jing et al. LANCET INFECTIOUS DISEASES
- Household Transmission of SARS-CoV-2 in the United States
- (2020) Nathaniel M Lewis et al. CLINICAL INFECTIOUS DISEASES
- A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters
- (2020) Yanshan Zhu et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started